Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jack

Showing results (351-360 of 594) with videos related to

Pageof 60
Sort By:
The Annals of Thoracic Surgery|October 8, 2003
The risk of second primary tumors after resection of stage I nonsmall cell lung cancerDavid Rice, Hyung-Woo Kim, Anita Sabichi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancyVassiliki A Papadimitrakopoulou, J Jack Lee, William N William, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 9, 2016
Transforming Cancer Prevention through Precision Medicine and Immune-oncologyThomas W Kensler, Avrum Spira, Judy E Garber, et al.
American Journal of Cancer Research|December 23, 2015
Expression pattern of FGFR2, Grb2 and Plcγ1 acts as a novel prognostic marker of recurrence recurrence-free survival in lung adenocarcinomaZahra Timsah, Jonathan Berrout, Milind Suraokar, et al.
International Journal of Epidemiology|July 31, 2018
Primary prevention of rheumatic fever in the 21st century: evaluation of a national programmeSusan J Jack, Deborah A Williamson, Yvonne Galloway, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 2, 2011
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancerAnita L Sabichi, J Jack Lee, H Barton Grossman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutationMaria G Raso, Carmen Behrens, Matthew H Herynk, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trialAnne S Tsao, Suyu Liu, J Jack Lee, et al.
Oncotarget|May 15, 2013
P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapyRabin Said, David S Hong, Carla L Warneke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trialOmar Eton, Sewa S Legha, Agop Y Bedikian, et al.
Pageof 60

Showing results (351-360 of 594) with videos related to

Sort By:
Pageof 60
The Annals of Thoracic Surgery|October 8, 2003
The risk of second primary tumors after resection of stage I nonsmall cell lung cancerDavid Rice, Hyung-Woo Kim, Anita Sabichi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancyVassiliki A Papadimitrakopoulou, J Jack Lee, William N William, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 9, 2016
Transforming Cancer Prevention through Precision Medicine and Immune-oncologyThomas W Kensler, Avrum Spira, Judy E Garber, et al.
American Journal of Cancer Research|December 23, 2015
Expression pattern of FGFR2, Grb2 and Plcγ1 acts as a novel prognostic marker of recurrence recurrence-free survival in lung adenocarcinomaZahra Timsah, Jonathan Berrout, Milind Suraokar, et al.
International Journal of Epidemiology|July 31, 2018
Primary prevention of rheumatic fever in the 21st century: evaluation of a national programmeSusan J Jack, Deborah A Williamson, Yvonne Galloway, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 2, 2011
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancerAnita L Sabichi, J Jack Lee, H Barton Grossman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutationMaria G Raso, Carmen Behrens, Matthew H Herynk, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trialAnne S Tsao, Suyu Liu, J Jack Lee, et al.
Oncotarget|May 15, 2013
P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapyRabin Said, David S Hong, Carla L Warneke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trialOmar Eton, Sewa S Legha, Agop Y Bedikian, et al.
Pageof 60